Ying Hou Selected Research

Lipopolysaccharides

10/2021	Therapeutic potential of isobavachalcone, a natural flavonoid, in murine experimental colitis by inhibiting NF-κB p65.
10/2019	Pseudoginsenoside-F11 Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Neutrophil Infiltration and Accelerating Neutrophil Clearance.
7/2010	Madecassoside suppresses LPS-induced TNF-alpha production in cardiomyocytes through inhibition of ERK, p38, and NF-kappaB activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ying Hou Research Topics

Disease

26	Neoplasms (Cancer) 01/2024 - 06/2006
6	Lung Neoplasms (Lung Cancer) 01/2024 - 01/2016
6	Inflammation (Inflammations) 02/2022 - 09/2017
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2016
5	Mitochondrial Diseases (Mitochondrial Disease) 03/2023 - 12/2017
5	Necrosis 01/2023 - 01/2020
4	Parkinson Disease (Parkinson's Disease) 03/2024 - 03/2013
4	Infections 11/2023 - 07/2010
4	Colonic Neoplasms (Colon Cancer) 01/2023 - 01/2020
4	Dermatomyositis (Dermatopolymyositis) 01/2022 - 09/2017
3	Carcinogenesis 01/2024 - 06/2006
3	Hypertension (High Blood Pressure) 03/2023 - 09/2020
3	Insulin Resistance 03/2023 - 09/2020
3	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 01/2022
3	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 01/2019
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2021 - 04/2012
3	Tuberculosis (Tuberculoses) 01/2019 - 12/2011
2	Brain Injuries (Brain Injury) 05/2024 - 04/2012
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 05/2024 - 12/2020
2	Cerebral Hemorrhage 01/2024 - 09/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2024 - 11/2022
2	Prostatic Neoplasms (Prostate Cancer) 11/2023 - 12/2019
2	Myasthenia Gravis 01/2023 - 01/2022
2	Cognitive Dysfunction 01/2022 - 11/2011
2	Polymyositis 01/2022 - 09/2017
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2020
2	Stroke (Strokes) 10/2021 - 07/2017
2	Ischemic Stroke 10/2021 - 09/2020
2	Transient Ischemic Attack 10/2021 - 08/2020
2	Frailty 01/2021 - 01/2018
2	Wounds and Injuries (Trauma) 01/2021 - 01/2015
2	Fibrosis (Cirrhosis) 09/2020 - 07/2016
2	Glioma (Gliomas) 01/2020 - 01/2013
2	Body Weight (Weight, Body) 10/2019 - 01/2010
2	Hepatocellular Carcinoma (Hepatoma) 05/2018 - 01/2014
2	Hypoxia (Hypoxemia) 02/2018 - 10/2007
2	Hydronephrosis 12/2016 - 04/2006
2	Ureteral Obstruction 07/2016 - 01/2015
2	Morphine Dependence 11/2010 - 01/2010
2	Wilms Tumor (Wilm's Tumor) 10/2007 - 06/2006
1	Sialorrhea 03/2024
1	Edema (Dropsy) 01/2024
1	Papillomavirus Infections 11/2023

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 07/2022 - 06/2006
6	Therapeutic UsesIBA 10/2021 - 07/2010
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024 - 01/2020
4	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 01/2020
4	Protein Kinases (Protein Kinase)IBA 10/2022 - 12/2008
4	CalciumIBA 06/2022 - 10/2019
4	ocotillolIBA 10/2021 - 10/2019
4	pseudoginsenoside F11 (PF 11)IBA 10/2021 - 10/2019
4	Biomarkers (Surrogate Marker)IBA 10/2020 - 03/2015
3	Phosphotransferases (Kinase)IBA 01/2023 - 10/2019
3	Rituximab (Mabthera)FDA Link 01/2023 - 01/2022
3	quinone (benzoquinone)IBA 01/2023 - 01/2020
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 10/2007
3	NAD (NADH)IBA 01/2023 - 01/2020
3	AntibodiesIBA 01/2022 - 01/2019
3	Neuroprotective AgentsIBA 10/2021 - 08/2020
3	SaponinsIBA 10/2021 - 10/2019
3	LipopolysaccharidesIBA 10/2021 - 07/2010
2	taxifolinIBA 05/2024 - 12/2020
2	CateninsIBA 01/2024 - 09/2020
2	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 12/2020
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2024 - 12/2017
2	enasidenibIBA 01/2024 - 11/2022
2	acacetinIBA 03/2023 - 09/2020
2	FructoseIBA 03/2023 - 09/2020
2	Insulin (Novolin)FDA Link 03/2023 - 09/2020
2	MicroRNAs (MicroRNA)IBA 01/2023 - 01/2014
2	Long Noncoding RNAIBA 01/2023 - 02/2019
2	IronIBA 01/2023 - 10/2021
2	FlavonoidsIBA 06/2022 - 10/2021
2	SolutionsIBA 02/2022 - 01/2021
2	SteroidsIBA 01/2022 - 04/2012
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2021
2	Dextran SulfateIBA 01/2022 - 10/2021
2	nannocystin AxIBA 11/2021 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 11/2019
2	Messenger RNA (mRNA)IBA 01/2021 - 06/2006
2	geniposideIBA 01/2021 - 12/2020
2	Estrogen ReceptorsIBA 12/2020 - 09/2020
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 09/2020 - 06/2006
2	JNK Mitogen-Activated Protein KinasesIBA 01/2020 - 10/2019
2	2-methoxy-6-acetyl-7-methyljugloneIBA 01/2020 - 10/2019
2	CytokinesIBA 11/2019 - 07/2016
2	Tuberculin (PPD)IBA 01/2019 - 12/2011
2	InterferonsIBA 01/2019 - 12/2011
2	Epidermal Growth Factor (EGF)IBA 01/2013 - 04/2006
2	Morphine (MS Contin)FDA LinkGeneric 01/2012 - 01/2010
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 06/2006 - 04/2006
1	Oxygen (Dioxygen)IBA 01/2024

Therapy/Procedure

5	Radiotherapy 01/2018 - 01/2016
4	Deep Brain Stimulation 03/2024 - 01/2021
4	Therapeutics 03/2024 - 12/2016
2	Immunotherapy 10/2022 - 11/2012
2	Intraperitoneal Injections 02/2022 - 10/2019
2	Drug Therapy (Chemotherapy) 01/2017 - 07/2010
1	Photochemotherapy (Photodynamic Therapy) 11/2023
1	Aftercare (After-Treatment) 11/2023